Skip to main content
. 2024 May 9;27(4):802–810. doi: 10.1007/s10120-024-01505-6

Table 2.

CLDN18 expression in primary tumors and peritoneal disseminations

(A)
40% cut-off CLDN18 in peritoneal disseminations
 −   + 

CLDN18 in

primary tumors

 −  33 (39.3%) 3 (3.6%)
 +  14 (16.7%) 34 (40.5%)
concordance rate 79.8% P* < 0.001
(B)
75% cut-off CLDN18 in peritoneal disseminations
 −   + 

CLDN18 in

primary tumors

 −  53 (63.1%) 7 (8.3%)
 +  14 (16.7%) 10 (11.9%)
concordance rate 75.0% P* = 0.005

CLDN Claudin

*Fisher’s exact test